Phosphatidylinositol-3-Kinase/Akt Regulates Bleomycin-Induced Fibroblast Proliferation and Collagen Production
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Abnormal repair and dysregulated angiogenesis have been implicated in the pathogenesis of pulmonary fibrosis, but the underlying mechanisms of regulation are not well understood. The present study investigated the role of phosphatidylinositol-3-kinase (PI3K)/Akt in fibrogenesis of human lung fibroblasts and its regulation by reactive oxygen species (ROS). Exposure of lung fibroblasts to bleomycin, a known inducer of fibrosis, resulted in rapid activation of PI3K/Akt and a parallel increase in fibroblast proliferation and collagen production, characteristics of lung fibrosis. Bleomycin had no significant effect on total Akt protein expression but induced phosphorylation of the protein at threonine 308 and serine 473 positions. Inhibition of this phosphorylation by PI3K inhibitors or by dominant-negative Akt (T308A/S473A) expression abrogated the effects of bleomycin on fibroblast proliferation and collagen production, suggesting the role of PI3K/Akt in the fibrogenic process. Activation of PI3K/Akt by bleomycin also led to transcriptional activation and protein expression of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor, which contributed to the fibroproliferative and collagen-inducing effects of bleomycin. The fibrogenic effects of bleomycin were dependent on ROS generation, particularly superoxide anion and hydrogen peroxide, which were induced by bleomycin. Inhibition of ROS generation by antioxidant enzymes, catalase and superoxide dismutase mimetic MnTBAP, abrogated the fibrogenic effects of bleomycin as well as its induction of PI3K/Akt and HIF-1α activation. Together, our results indicate a novel role of PI3K/Akt in fibrogenesis of human lung fibroblasts and its regulation by ROS, which could be exploited for the treatment of pulmonary fibrosis and related disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Overexpression of SMAD3 enhances, whereas knockdown inhibits αSMA and extracellular matrix production in fibroblasts (45–48). Furthermore, fibroblast-specific deletion of SMAD3 reduces αSMA production and myofibroblast phenotype (49–52), for example, loss of SMAD3 lowers the number of activated myofibroblasts in cardiac fibrosis in vivo and reduces extracellular matrix production by myofibroblasts”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tacchini, L. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh227 · Cited by 112
RetractedWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · cited 2×
“Consistent with previous reports showing the regulatory role of HIF-1a on VEGF expression (26, 27, 47), we found that VEGF gene and protein expression was also up-regulated by the bleomycin treatment and that this effect can be inhibited by the PI3K inhibitor LY294002 (Figures 4A–4C).”
BackgroundResultSelf-citationThe phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621 · cited 2×
“The PI3K/Akt pathway is involved in many cellular processes, including cell growth, differentiation, apoptosis, and angiogenesis (14, 15), and is commonly triggered by the activation of receptor tyrosine kinases, which leads to the translocation of PI3K from cytoplasm to plasma membrane.”
BackgroundMechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Self-citationSelman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,668
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
(2000) · PubMed · Cited by 1,445
Targeting the PI3K-Akt pathway in human cancer
Luo, J., Manning, B. D., & Cantley, L. C. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00248-4 · Cited by 1,290
Research works printed but not linked: 1
- 9. FlahertyKR,ToewsGB,LynchJPIII,KazerooniEA,GrossBH,Strawderman RL, Hariharan K, Flint A, Martinez FJ. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. AmJMed 2001;110:278-282.
Cited by
Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
Wang, J., Hu, K., Cai, X., Yang, B., He, Q., Wang, J., & Weng, Q. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.023 · Cited by 450
Autophagy in Idiopathic Pulmonary Fibrosis
Patel, A. S., Lin, L., Geyer, A., Haspel, J. A., An, C. H., Cao, J., Rosas, I. O., & Morse, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041394 · Cited by 372
The Akt pathway in oncology therapy and beyond (Review)
Nitulescu, G., Van De Venter, M., Nitulescu, G., Ungurianu, A., Juzenas, P., Peng, Q., Olaru, O., Grădinaru, D., Tsatsakis, A., Tsoukalas, D., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4597 · Cited by 328
Hsu, H.-S., Liu, C.-C., Lin, J.-H., Hsu, T.-W., Hsu, J.-W., Su, K., & Hung, S.-C. (2017) · Scientific Reports · doi:10.1038/s41598-017-14612-5 · Cited by 205
Jun, E., Zhang, Q., Yoon, B., Moon, J.-H., Lee, G., Park, G., Kang, P., Lee, J., Kim, A., & You, S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15010605 · Cited by 176
Conte, E., Fruciano, M., Fagone, E., Gili, E., Caraci, F., Iemmolo, M., Crimi, N., & Vancheri, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024663 · Cited by 162
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney Disease
Liu, J., Wei, Q., Guo, C., Dong, G., Liu, Y., Tang, C., & Dong, Z. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050950 · Cited by 131
Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway
Saito, S., Zhuang, Y., Shan, B., Danchuk, S. D., Luo, F., Korfei, M., Günther, A., & Lasky, J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186615 · Cited by 127
Zhao, H., Li, C., Li, L., Liu, J., Gao, Y., Mu, K., Chen, D., Lu, A., Ren, Y., & Li, Z. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11046 · Cited by 140
Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis
Campa, C. C., Silva, R. L., Margaria, J. P., Pirali, T., Mattos, M. S., Kraemer, L. R., Reis, D. C., Grosa, G., Copperi, F., Dalmarco, E. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07698-6 · Cited by 113
Palanivel, C., Gowrikumar, S., Manikandan, R., & Sudhandiran, G. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1283-1 · Cited by 107
Li, J., Pan, Y., Kan, M., Xiao, X., Wang, Y., Guan, F., Zhang, X., & Chen, L. (2014) · Life Sciences · doi:10.1016/j.lfs.2013.12.211 · Cited by 94
Pulmonary fibrosis: from mechanisms to therapies
Jiang, M., Bu, W., Wang, X., Ruan, J., Shi, W., Yu, S., Huang, L., Xue, P., Tang, J., Zhao, X., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06514-2 · Cited by 120
Azad, N., Iyer, A. K. V., Wang, L., Liu, Y., Lu, Y., & Rojanasakul, Y. (2012) · Nanotoxicology · doi:10.3109/17435390.2011.647929 · Cited by 95
Self-citationKim, S.-Y., Lee, J.-H., Kim, H. J., Park, M. K., Huh, J. W., Ro, J. Y., Oh, Y.-M., Lee, S.-D., & Lee, Y.-S. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00288.2011 · Cited by 88
Loss of PTEN Expression by Dermal Fibroblasts Causes Skin Fibrosis
Parapuram, S. K., Shiwen, X., Elliott, C. G., Welch, I. D., Jones, H., Baron, M. G., Denton, C. P., Abraham, D., & Leask, A. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.156 · Cited by 91
Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy
Zanotti, S., Gibertini, S., Curcio, M., Savadori, P., Pasanisi, M. B., Morandi, L. O., Cornelio, F., Mantegazza, R., & Mora, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.013 · Cited by 89
Russo, R. C., Garcia, C. C., Barcelos, L. S., Rachid, M. A., Guabiraba, R., Roffê, E., Souza, A. L. S., Sousa, L. P., Mirolo, M., Doni, A., et al. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0610346 · Cited by 73
Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment
Ghebremedhin, A., Athavale, D., Zhang, Y.-T. Y., Yao, X., Balch, C., & Song, S. (2024) · Cancers · doi:10.3390/cancers16193410 · Cited by 92
Targeting type I collagen for cancer treatment
Shi, R., Zhang, Z., Zhu, A.-K., Xiong, X., Zhang, J., Xu, J., Sy, M., & Li, C. (2022) · International Journal of Cancer · doi:10.1002/ijc.33985 · Cited by 81
Kondrikov, D., Caldwell, R. B., Dong, Z., & Su, Y. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.020 · Cited by 71
Nitric Oxide Mediates Bleomycin‐induced Angiogenesis and Pulmonary Fibrosis via Regulation of VEGF
Iyer, A. K. V., Ramesh, V., Castro, C. A., Kaushik, V., Kulkarni, Y. M., Wright, C. A., Venkatadri, R., Rojanasakul, Y., & Azad, N. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25192 · Cited by 67
Self-citationTargeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option
Korfei, M., Mahavadi, P., & Guenther, A. (2022) · Cells · doi:10.3390/cells11101626 · Cited by 72
The role of RhoA and cytoskeleton in myofibroblast transformation in hyperoxic lung fibrosis
Ni, J., Dong, Z., Han, W., Kondrikov, D., & Su, Y. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.012 · Cited by 56
The evolution ofin vitromodels of lung fibrosis: promising prospects for drug discovery
Kolanko, E., Cargnoni, A., Papait, A., Silini, A. R., Czekaj, P., & Parolini, O. (2024) · European Respiratory Review · doi:10.1183/16000617.0127-2023 · Cited by 56
Kim, S.-J., Cheresh, P., Eren, M., Jablonski, R. P., Yeldandi, A. V., Ridge, K. M., Budinger, G. R. S., Kim, D., Wolf, M. S., Vaughan, D. E., et al. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00063.2017 · Cited by 51
Liu, Z., Liu, X., Bao, L., Liu, J., Zhu, X., Mo, X., & Tang, R. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120999 · Cited by 44
Tran, T. A., Ho, M. T., Song, Y. W., Cho, M., & Cho, S. K. (2015) · Phytotherapy Research · doi:10.1002/ptr.5484 · Cited by 48
“Scar-cinoma”: viewing the fibrotic lung mesenchymal cell in the context of cancer biology
Horowitz, J. C., Osterholzer, J. J., Marazioti, A., & Stathopoulos, G. T. (2016) · European Respiratory Journal · doi:10.1183/13993003.01201-2015 · Cited by 47
Chung, C.-W., Zhang, Q. L., & Qiao, L. Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.040444 · Cited by 43
A Promising Candidate in Tendon Healing Events—PDGF-BB
Chen, Y., Jiang, L., Lyu, K., Lu, J., Long, L., Wang, X., Liu, T., & Li, S. (2022) · Biomolecules · doi:10.3390/biom12101518 · Cited by 41
Sun, H., Ren, C., Lee, D. H., Wang, W., Guo, X., Hao, Y., Wang, X., Zhang, H., Xiao, W.-Q., Li, N., et al. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00460-x · Cited by 42
Animal models of systemic sclerosis: their utility and limitations
Artlett, C. M. (2014) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s50009 · Cited by 50
Recent advances in mouse models for systemic sclerosis
Yue, X., Yu, X., Petersen, F., & Riemekasten, G. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.06.013 · Cited by 45
Sun, H., Calle, E. A., Chen, X., Mathur, A., Zhu, Y., Mendez, J. J., Zhao, L., Niklason, L. E., Peng, X., Peng, H., et al. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00100.2013 · Cited by 40
Larson‐Casey, J. L., Murthy, S., Ryan, A. J., & Carter, A. B. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.593285 · Cited by 37
New therapeutics based on emerging concepts in pulmonary fibrosis
Sontake, V., Gajjala, P. R., Kasam, R. K., & Madala, S. K. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1552262 · Cited by 34
Park, S. J., Lee, K. S., Lee, S. J., Kim, S. R., Park, S. Y., Jeon, M. S., Lee, H. B., & Lee, Y. C. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13077915 · Cited by 34
Yang, L., Lin, Z., Wang, Y., Li, C., Xu, W., Li, Q., Yao, W., Song, Z., & Liu, G. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-0525-x · Cited by 33
PI3K/Akt in IPF: untangling fibrosis and charting therapies
Bhatt, J., Ghigo, A., & Hirsch, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1549277 · Cited by 41
Somade, O. T., Adeyi, O. E., Ajayi, B. O., Asunde, O. O., Iloh, P. D., Adesanya, A. A., Babalola, O. I., Folorunsho, O. T., Olakunle, D. A., & Lawal, O. F. (2022) · Metabolism Open · doi:10.1016/j.metop.2022.100179 · Cited by 35
Tiriveedhi, V., Gelman, A. E., & Mohanakumar, T. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.11.006 · Cited by 32
Muthuramalingam, K., Cho, M., & Kim, Y. (2019) · Cell Biology International · doi:10.1002/cbin.11248 · Cited by 33
Tong, B., Fu, L., Hu, B., Zhang, Z., Tan, Z.-X., Li, S.-R., Chen, Y., Zhang, C., Wang, H., Xu, D., et al. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01514-6 · Cited by 35
Inhibition of TRPM7 channels prevents proliferation and differentiation of human lung fibroblasts
Yu, M., Huang, C. Z., Huang, Y., Wu, X., Li, X., & Li, J. (2013) · Inflammation Research · doi:10.1007/s00011-013-0653-9 · Cited by 34
Multi-omics analysis reveals the mechanism of action of ophiopogonin D against pulmonary fibrosis
Bao, S., Chen, T., Chen, J., Zhang, J., Zhang, G., Hui, Y., Li, J., & Yan, S. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155078 · Cited by 31
Kulkarni, Y. M., Dutta, S. M., Iyer, A. K. V., Venkatadri, R., Kaushik, V., Ramesh, V., Wright, C. A., Semmes, O. J., Yakisich, J. S., & Azad, N. (2015) · PROTEOMICS · doi:10.1002/pmic.201500171 · Cited by 34
Self-citationTargeting the isoprenoid pathway to abrogate progression of pulmonary fibrosis
Osborn, H. L., Murthy, S., Gu, L., Larson‐Casey, J. L., Ryan, A. J., Shi, L., Glogauer, M., Neighbors, J. D., Hohl, R. J., & Carter, A. B. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.031 · Cited by 29
Kulkarni, Y. M., Dutta, S. M., Iyer, A. K. V., Wright, C. A., Ramesh, V., Kaushik, V., Semmes, O. J., & Azad, N. (2017) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201700086 · Cited by 30
Self-citationThe Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis
Zhu, J., Liu, L., Ma, X., Cao, X., Chen, Y., Qu, X., Ji, M. H., Liu, H., Liu, C., Qin, X., et al. (2022) · Antioxidants · doi:10.3390/antiox11112292 · Cited by 36
Hypoxia-Induced Epithelial-Mesenchymal Transition Is Involved in Bleomycin-Induced Lung Fibrosis
Guo, L., Xu, J., Liu, L., Liu, S.-M., & Zhu, R. (2015) · BioMed Research International · doi:10.1155/2015/232791 · Cited by 30
Yang, F., Hou, R., Liu, X., Tian, Y., Bai, Y., Li, J., & Zhao, P. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154622 · Cited by 27
An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis
Arif, M., Basu, A., Wolf, K. M., Park, J. K., Pommerolle, L., Behee, M., Gochuico, B. R., & Çınar, R. (2023) · Advanced Science · doi:10.1002/advs.202207454 · Cited by 30
Lv, M., Liu, Y., Ma, S., & Yu, Z. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0111 · Cited by 28
Hussein, R. M., Arafa, E. A., Raheem, S. A., & Mohamed, W. R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121256 · Cited by 28
Expression and significance of HIF-1α in pulmonary fibrosis induced by paraquat
Xie, H., Tan, J., Wang, R., Meng, X., Xue Ming, T. A. N. G., & Gao, S. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213498978 · Cited by 23
Jiang, Y., Xie, Y., Peng, C.-W., Yao, K., Xue-ying, L., Zhan, S., Zhuang, H., Huang, H.-T., Liu, X.-H., Huang, X., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865097 · Cited by 27
Tu, M., Wei, T., Jia, Y., Wang, Y., & Wu, J. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-22-886 · Cited by 29
Roflumilast Prevents the Metabolic Effects of Bleomycin-Induced Fibrosis in a Murine Model
Milara, J., Morcillo, E. J., Monleón, D., Tenor, H., & Cortijo, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133453 · Cited by 27
Tackling MARCKS‐PIP3 circuit attenuates fibroblast activation and fibrosis progression
Yang, D. C. H., Li, J., Xu, J., Oldham, J. M., Phan, S. H., Last, J. A., Wu, R., & Chen, C. (2019) · The FASEB Journal · doi:10.1096/fj.201901705r · Cited by 28
Di, R., Yang, Z., Xu, P., & Xu, Y. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7627 · Cited by 26
Mansour, S. M., El-Abhar, H. S., & Soubh, A. A. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00748-w · Cited by 21
Hypoxic Culture and Insulin Yield Improvements to Fibrin-Based Engineered Tissue
Bjork, J. W., Meier, L. A., Johnson, S. L., Syedain, Z. H., & Tranquillo, R. T. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0017 · Cited by 22
Liu, R., Chen, H., Bai, H., Zhang, W., Wang, X., Qin, X.-J., Zhang, X., Li, W., Liang, X., & Hai, C. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.03.034 · Cited by 20
Cigarette Smoke Exacerbates Ventricular Remodeling and Dysfunction in the Volume Overloaded Heart
Bradley, J., Nguyen, J. B., Fournett, A. C., & Gardner, J. D. (2011) · Microscopy and Microanalysis · doi:10.1017/s1431927611012207 · Cited by 20
Ridge, P. G., Maxwell, T. J., Foutz, S. J., Bailey, M. H., Corcoran, C. D., Tschanz, J. T., Norton, M. C., Munger, R. G., O’Brien, E., Kerber, R. A., et al. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-s7-s6 · Cited by 20
Human Adventitial Fibroblast Phenotype Depends on the Progression of Changes in Substrate Stiffness
Scott, R. A., Robinson, K. G., Kiick, K. L., & Akins, R. E. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901593 · Cited by 19
Iron overload and mitochondrial dysfunction orchestrate pulmonary fibrosis
Li, S., Zhang, H., Chang, J., Li, D., & Cao, P. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174613 · Cited by 30
AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis
Cross, J. L., Stenton, G. R., Harwig, C., Szabó, C., Genovese, T., Paola, R. D., Esposito, E., Cuzzocrea, S., & Mackenzie, L. F. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13934 · Cited by 21
Zhu, D., Yu, Q., Sun, J., & Shen, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.733618 · Cited by 19
MnTBAP Inhibits Bleomycin-Induced Pulmonary Fibrosis by Regulating VEGF and Wnt Signaling
Venkatadri, R., Iyer, A. K. V., Ramesh, V., Wright, C. A., Castro, C. A., Yakisich, J. S., & Azad, N. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25608 · Cited by 19
Self-citationLatest progress on the molecular mechanisms of idiopathic pulmonary fibrosis
Fang, Y., Tian, J., Fan, Y., & Cao, P. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-06000-6 · Cited by 22
The Antiretroviral Agent Nelfinavir Mesylate
Sánchez, C. G., Molinski, S. V., Gongora, R., Sosulski, M. L., Fuselier, T. T., MacKinnon, S. S., Mondal, D., & Lasky, J. A. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40326 · Cited by 17
Wang, Y., Hu, S., Shen, L., Liu, S., Wan, L., Yang, S., Hou, M., Tian, X., Zhang, H., & Xu, K. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.664913 · Cited by 18
PTGES is involved in myofibroblast differentiation via HIF ‐1α‐dependent glycolysis pathway
Lin, M., Lee, Y., Liao, J., Chou, C., & Yang, Y. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70157 · Cited by 19
Adegunsoye, A., Baccile, R., Best, T. J., Zaksas, V., Hui, Z., Karnik, R., Patel, B. K., Solomonides, A. E., Parker, W. F., & Solway, J. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2023.100566 · Cited by 22
Yu, X., Xia, Y., Zeng, L., Zhang, X., Chen, L., Yan, S., Zhang, R., Zhao, C., Zeng, Z., Shu, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29417-3 · Cited by 17
Dakhlallah, D. A., Wang, Y., Bobo, T. A., Ellis, E., Mo, X. M., Piper, M. G., Eubank, T. D., & Marsh, C. B. (2019) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2019.1010027 · Cited by 17
Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications
NAIR, G. B., Matela, A., Kurbanov, D., & Raghu, G. (2016) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2016.1177461 · Cited by 14
Liu, Z., Rütten, S., Buhl, E. M., Zhang, M., Liu, J., Rojas‐González, D. M., & Mela, P. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300184 · Cited by 17
A narrative review of the role of HDAC6 in idiopathic pulmonary fibrosis
Yu, H., Liu, S., Wang, S., & Gu, X. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1183 · Cited by 16
Wang, X., Li, H., Zhang, A., Zhang, Y., Li, Z., Wang, X., Gao, M., Zhang, Y., & Hou, Y. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106074 · Cited by 19
The code of non-coding RNAs in lung fibrosis
Cui, H., Xie, N., Thannickal, V. J., & Liu, G. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1939-6 · Cited by 15
Ding, Q., Yang, W., Xue, G., Liu, H., Cai, Y., Que, J., Jin, X., Luo, M., Pang, F., Yang, Y., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03385-6 · Cited by 14
Clevenger, A. J., Jimenez‐Vergara, A. C., Tsai, E. H., Righes, G. D. B., Díaz‐Lasprilla, A. M., Ramírez‐Caballero, G. E., & Munoz‐Pinto, D. J. (2022) · Gels · doi:10.3390/gels9010028 · Cited by 11
Nitrite Prevents Right Ventricular Failure and Remodeling Induced by Pulmonary Artery Banding
HU, J. L., Sharifi‐Sanjani, M., & Tofovic, S. P. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000446 · Cited by 12
Hao, J., Du, H., Li, W., Liu, F., Lu, J., Yang, X., & Cui, W. (2016) · PubMed · Cited by 11
Anti-Fibrotic Effects by Moringa Root Extract in Rat Kidney Fibroblast
Park, S. H., & Chang, Y. (2012) · Journal of Life Science · doi:10.5352/jls.2012.22.10.1371 · Cited by 10
Li, K., Liu, X., Hou, R., Zhao, H., Zhao, P., Tian, Y., & Li, J. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115082 · Cited by 9
Exogenous supply of Hsp47 triggers fibrillar collagen deposition in skin cell cultures in vitro
Khan, E. S., Sankaran, S., Llontop, L., & del Campo, A. (2020) · BMC Molecular and Cell Biology · doi:10.1186/s12860-020-00267-0 · Cited by 9
Yoshikawa, E., Matsui‐Yuasa, I., Huang, X., Kobayashi, Y., & Kojima‐Yuasa, A. (2020) · Food Science & Nutrition · doi:10.1002/fsn3.1709 · Cited by 9
Sunarto, H., Trisnadi, S., Putra, A. B., Sadyah, N. A. C., Tjipta, A., & Chodidjah, C. (2020) · Indonesian Journal of Cancer Chemoprevention · doi:10.14499/indonesianjcanchemoprev11iss3pp134-143 · Cited by 18
Ketotifen directly modifies the fibrotic response of human skin fibroblasts
Leong, E. K., Bitar, H. A., Marshall, J. S., & Bezuhly, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-57776-7 · Cited by 8
Zhang, A., Zou, Y., Xu, Q., Tian, S., Wang, J., Li, Y., Dong, R., Zhang, L., Jiang, J., Wang, L., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.919388 · Cited by 7
Self-citationLung carcinogenesis and fibrosis taken together: just coincidence?
Giopanou, I., Arendt, K. A. M., & Stathopoulos, G. T. (2017) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000390 · Cited by 7
SRT1720, a SIRT1 Activator, Aggravates Bleomycin-Induced Lung Injury in Mice
Imanishi, S., Hayashi, R., Ichikawa, T., Suzuki, K., Sasahara, M., Kondo, T., Ogawa, H., & Tobe, K. (2012) · Food and Nutrition Sciences · doi:10.4236/fns.2012.32024 · Cited by 7
Brun, E. H. C., Hong, Z.-Y., Hsu, Y.-M., Wang, C.-T., Chung, D.-J., Ng, S.-K., Lee, Y.-H., & Wei, T.-T. (2023) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2022.0020 · Cited by 6
Feng, T., Duan, R., Zheng, P., Qiu, J. Y., Li, Q., & Li, W. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11897 · Cited by 6
Gui, L., Wang, S., Miao, S., Qiao, M., Jiao, Y., Chen, H., Li, W., Zou, J., & Du, X. C. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101950 · Cited by 8
Metadata
- Authors
- Lu, Y., Azad, N., Wang, L., Iyer, A. K. V., Castranova, V., Jiang, B.-H., & Rojanasakul, Y.
- Affiliations
- Department of Pharmaceutical Sciences and
- Hampton University (US)
- National Institute for Occupational Safety and Health (US)
- West Virginia University (US)
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-01
- Volume
- 42
- Issue
- 4
- Pages
- 432-441
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- PMC
- PMC2848736
- OpenAlex
- W2153557413
- Cited by
- 138
- References
- 53
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 13 · 2022: 13 · 2021: 10 · 2020: 15 · 2019: 5 · 2018: 7 · 2017: 10 · 2016: 5 · 2015: 10 · 2014: 6 · 2013: 7 · 2012: 6
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01-HL76340, R01HL076340)
- National Institute for Occupational Safety and Health
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- phosphatidylinositol 3-kinase/Akt signaling, pulmonary fibrosis, bleomycin, lung fibroblasts, fibroblast proliferation, collagen synthesis, reactive oxygen species, superoxide, hydrogen peroxide, hypoxia-inducible factor-1α, vascular endothelial growth factor, Akt phosphorylation, catalase, fibrogenesis
- MeSH terms
- Phosphoinositide-3 Kinase Inhibitors, Antibiotics, Antineoplastic, Antioxidants, Bleomycin, Cell Line, Collagen, Enzyme Activation, Enzyme Inhibitors, Fibroblasts, Humans, Lung, Neovascularization, Pathologic, Oxidoreductases, Phosphorylation, Pulmonary Fibrosis, Transcription, Genetic, Reactive Oxygen Species, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.